Loss-of-function CYP2C9 variants improve therapeutic response to sulfonylureas in type 2 diabetes: a Go-DARTS study.

Loss-of-function CYP2C9 variants improve therapeutic response to sulfonylureas in type 2 diabetes: a Go-DARTS study.

Sulfonylureas are metabolized mainly by the cytochrome p450 2C9 (CYP2C9) enzyme. Two CYP2C9 variants--*2 (Arg144Cys) and *3 (Ile359Leu)--are associated with reduced enzyme activity and impaired substrate metabolism. We identified 1,073 incident users of sulfonylureas in Tayside, Scotland, and assess...

Full description

Bibliographic Details
Main Authors:	Zhou, K, Donnelly, L, Burch, L, Tavendale, R, Doney, A, Leese, G, Hattersley, A, McCarthy, M, Morris, A, Lang, C, Palmer, C, Pearson, E
Format:	Journal article
Language:	English
Published:	2010

Similar Items

Variation in TCF7L2 influences therapeutic response to sulfonylureas: a GoDARTs study.
by: Pearson, E, et al.
Published: (2007)

Common nonsynonymous substitutions in SLCO1B1 predispose to statin intolerance in routinely treated individuals with Type 2 diabetes: A Go-DARTS study
by: Donnelly, L, et al.
Published: (2011)

Common nonsynonymous substitutions in SLCO1B1 predispose to statin intolerance in routinely treated individuals with type 2 diabetes: a go-DARTS study.
by: Donnelly, L, et al.
Published: (2011)

TCF7L2 in the Go-DARTS study: evidence for a gene dose effect on both diabetes susceptibility and control of glucose levels.
by: Kimber, C, et al.
Published: (2007)

Reduced-function SLC22A1 polymorphisms encoding organic cation transporter 1 and glycemic response to metformin: a GoDARTS study.
by: Zhou, K, et al.
Published: (2009)

Metformin Pharmacogenetics and SLC2A2: Genome-Wide Association Study and 2-stage replication in GoDARTS and UKPDS
by: Zhou, K, et al.
Published: (2013)

Pharmacogenetics in Type 2 diabetes: variation in TCF7L2 influences response to sulphonylureas
by: Pearson, E, et al.
Published: (2007)

The ATPase activities of sulfonylurea receptor 2A and sulfonylurea receptor 2B are influenced by the C-terminal 42 amino acids.
by: de Wet, H, et al.
Published: (2010)

The ATPase activities of sulfonylurea receptor 2A and sulfonylurea receptor 2B are influenced by the C-terminal 42 amino acids
by: De Wet, H, et al.
Published: (2010)

Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations.
by: Pearson, E, et al.
Published: (2006)

The sulfonylurea receptor.
by: Ashcroft, S, et al.
Published: (1992)

The beta-cell sulfonylurea receptor.
by: Ashcroft, S, et al.
Published: (1993)

One-year glycemic control with a sulfonylurea plus pioglitazone versus a sulfonylurea plus metformin in patients with type 2 diabetes.
by: Hanefeld, M, et al.
Published: (2004)

Mechanisms of the glycaemic effects of sulfonylureas.
by: Ashcroft, F
Published: (1996)

Heterogeneity of the CYP2D6 gene among Malays in Malaysia
by: Teh, L.K., et al.
Published: (2001)

Fine-tuned photochromic sulfonylureas for optical control of beta cell Ca2+ fluxes
by: Rückert, A-K, et al.
Published: (2023)

Improving the affinity and activity of CYP101D2 for hydrophobic substrates.
by: Bell, S, et al.
Published: (2013)

Improving the affinity and activity of CYP101D2 for hydrophobic substrates.
by: Bell, S, et al.
Published: (2013)

Common polymorphisms in the CYP11B1 and CYP11B2 genes: evidence for a digenic influence on hypertension.
by: Alvarez-Madrazo, S, et al.
Published: (2013)

Common polymorphisms in the CYP11B1 and CYP11B2 genes: Evidence for a digenic influence on hypertension
by: Alvarez-Madrazo, S, et al.
Published: (2013)

Learning from molecular genetics: novel insights arising from the definition of genes for monogenic and type 2 diabetes.
by: McCarthy, M, et al.
Published: (2008)

Paradoxical lower serum triglyceride levels and higher type 2 diabetes mellitus susceptibility in obese individuals with the PNPLA3 148M variant.
by: Palmer, C, et al.
Published: (2012)

Mutations of the same conserved glutamate residue in NBD2 of the sulfonylurea receptor 1 subunit of the KATP channel can result in either hyperinsulinism or neonatal diabetes.
by: Männikkö, R, et al.
Published: (2011)

DART and laboratory monitoring of HIV treatment Reply
by: Walker, A, et al.
Published: (2010)

Permanent neonatal diabetes due to mutations in KCNJ11 encoding Kir6.2: patient characteristics and initial response to sulfonylurea therapy.
by: Sagen, J, et al.
Published: (2004)

The dynamics of camphor in the cytochrome P450 CYP101D2.
by: Vohra, S, et al.
Published: (2013)

Growth inhibition of pathogenic bacteria by sulfonylurea herbicides
by: Krishna, Aishwarya, et al.
Published: (2015)

Influence of CYP2C19 genotype on the pharmacokinetics of R483, a CYP2C19 substrate, in healthy subjects and type 2 diabetes patients
by: Bogman, K., et al.
Published: (2010)

Population Pharmacokinetics Of Repaglinide In Healthy Subjects And Genetic Polymorphisms Of Cyp3a4 And Cyp2c8
by: Abu Bakar, Ruzilawati
Published: (2008)

CYTOCHROME P450 EPOXYGENASE 2J2 (CYP2J2) AND IT'S METABOLITES ARE UPREGULATED IN PREECLAMPSIA
by: Herse, F, et al.
Published: (2011)

Cytochrome P450 Epoxygenase 2J2 (CYP2J2) and it's Metabolites are Upregulated in Preeclampsia
by: Herse, F, et al.
Published: (2010)

Cloning and expression of CYP2D6*1 and CYP2D6*10 and its application in vitro drug-herbs interaction studies
by: Lee, Wee Leng
Published: (2013)

Novel mutations in the CYP4v2 gene associated with Bietti crystalline corneoretinal dystrophy
by: Halford, S, et al.
Published: (2007)

Polymorphisms of the CYP2D6 gene increase susceptibility to ankylosing spondylitis.
by: Brown, M, et al.
Published: (2000)

Polymorphisms of the CYP2D6 gene increase susceptibility to ankylosing spondylitis.
by: Brown, M, et al.
Published: (1998)

PKC-dependent stimulation of exocytosis by sulfonylureas in pancreatic beta cells.
by: Eliasson, L, et al.
Published: (1996)

Interaction of the cytosolic domains of the Kir6.2 subunit of the K(ATP) channel is modulated by sulfonylureas.
by: Lippiat, J, et al.
Published: (2002)

UKPDS 28: A randomized trial of efficacy of early addition of metformin in sulfonylurea-treated type 2 diabetes
by: Wright, A, et al.
Published: (1998)

The crystal structures of 4-methoxybenzoate bound CYP199A2 and CYP199A4: structural changes on substrate binding and the identification of an anion binding site.
by: Bell, S, et al.
Published: (2012)

Association of the CYP11B1 and CYP11B2 gene polymorphisms with hypertension in the British Genetics of Hypertension case-control study
by: Padmanabhan, S, et al.
Published: (2007)